Premium
Effects of Folic Acid and Folinic Acid on Pyrimethamine Teratogenesis in Rats
Author(s) -
KUDO Gen,
KOKUE Eiichi,
HAYAMA Toyoaki
Publication year - 1988
Publication title -
congenital anomalies
Language(s) - English
Resource type - Journals
eISSN - 1741-4520
pISSN - 0914-3505
DOI - 10.1111/j.1741-4520.1988.tb00969.x
Subject(s) - folinic acid , pyrimethamine , folic acid , teratology , pharmacology , antifolate , chemistry , medicine , fetus , methotrexate , pregnancy , chemotherapy , biology , immunology , malaria , antimetabolite , chloroquine , fluorouracil , genetics
The effects of folic acid (FA) and folinic acid (FNA) on the tera‐togenicity of the antifolate drug pyrimethamine (PYR) were examined in rats. PYR and FA were orally administered with mashed feed. FNA was intraperitoneal‐ly injected. The drugs were administered for 5 days of day 11–15 of gestation. Six groups were made; G‐I PYR 1.6 (mg/kg/day), G‐II PYR 3.6, G‐HI PYR 1.6 + FA 50, G‐IV PYR 3.6 + FNA 12, G‐V FA 50, G‐VI control. No malformations were found in G‐I, IV, V and VI. All fetuses in G‐II and HI had malformations. Main malformations in G‐II and III were cleft palate and brachygnathia. Accordingly it might be demonstrated that the teratogenicity of PYR was potentiated by concurrent FA in rats.